Pages that link to "Q46431183"
Jump to navigation
Jump to search
The following pages link to Severity of diabetic microvascular complications is associated with a low soluble RAGE level (Q46431183):
Displaying 33 items.
- Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology (Q26744760) (← links)
- Molecular Markers of Diabetic Retinopathy: Potential Screening Tool of the Future? (Q26745555) (← links)
- Advanced glycation end-products and their receptor-mediated roles: inflammation and oxidative stress (Q30426453) (← links)
- Estrogen replacement therapy in diabetic ovariectomized female rats potentiates postischemic leukocyte adhesion in cerebral venules via a RAGE-related process (Q33509786) (← links)
- Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging (Q34094369) (← links)
- -374 T/A RAGE polymorphism is associated with chronic kidney disease progression in subjects affected by nephrocardiovascular disease. (Q34672674) (← links)
- On the significance of new biochemical markers for the diagnosis of premature labour (Q34762626) (← links)
- Soluble receptors for advanced glycation end products and receptor activator of NF-κB ligand serum levels as markers of premature labor. (Q35658848) (← links)
- 2245G/A polymorphism of the receptor for advanced glycation end-products (RAGE) gene is associated with diabetic retinopathy in the Malaysian population. (Q35682226) (← links)
- Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus (Q35914764) (← links)
- Association between serum endogenous secretory receptor for advanced glycation end products and risk of type 2 diabetes mellitus with combined depression in the Chinese population (Q36281725) (← links)
- Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus. (Q36574142) (← links)
- Clinical study of advanced glycation end products in egyptian diabetic obese and non-obese patients (Q36735682) (← links)
- Soluble receptor for advanced glycation end-product (sRAGE)/pentosidine ratio: a potential risk factor determinant for type 2 diabetic retinopathy (Q36820462) (← links)
- Potential of the angiotensin receptor blockers (ARBs) telmisartan, irbesartan, and candesartan for inhibiting the HMGB1/RAGE axis in prevention and acute treatment of stroke. (Q37225236) (← links)
- Association of the receptor for advanced glycation end products gene polymorphisms and circulating RAGE levels with diabetic retinopathy in the Chinese population (Q37328633) (← links)
- Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect. (Q37382495) (← links)
- Complex tissue-specific patterns and distribution of multiple RAGE splice variants in different mammals (Q37430071) (← links)
- Soluble forms of RAGE in internal medicine. (Q37591246) (← links)
- RAGE and the pathogenesis of chronic kidney disease (Q37737557) (← links)
- Soluble Levels of Receptor for Advanced Glycation Endproducts (RAGE) and Progression of Atherosclerosis in Individuals Infected with Human Immunodeficiency Virus: ACTG NWCS 332. (Q40662634) (← links)
- Soluble and Endogenous Secretory Receptors for Advanced Glycation End Products in Threatened Preterm Labor and Preterm Premature Rupture of Fetal Membranes (Q40977776) (← links)
- Glycyrrhizic acid attenuated glycative stress in kidney of diabetic mice through enhancing glyoxalase pathway (Q46925426) (← links)
- Soluble form of receptor for advanced glycation end-products (sRAGE): do sRAGE ligands or anti-sRAGE auto-antibodies interfere with sRAGE quantification? (Q47686708) (← links)
- Circulating soluble RAGE isoforms are attenuated in obese, impaired-glucose-tolerant individuals and are associated with the development of type 2 diabetes (Q47948668) (← links)
- Clinical and Biological Predictors of Plasma Levels of Soluble RAGE in Critically Ill Patients: Secondary Analysis of a Prospective Multicenter Observational Study. (Q54941926) (← links)
- Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients. (Q55474587) (← links)
- The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review (Q59329530) (← links)
- Current literature in diabetes (Q83750291) (← links)
- Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes (Q84183344) (← links)
- Role of advanced glycation end product receptors in the pathogenesis of diabetic retinopathy (Q84661769) (← links)
- sRAGE Concentration İncreases Following the Treatment of Severe Diabetic Ketoacidosis (Q90080356) (← links)
- Type 1 Diabetes and Hearing Loss: Audiometric Assessment and Measurement of Circulating Levels of Soluble Receptor for Advanced Glycation End Products (Q90456192) (← links)